-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bellevue Life Sciences Acquisition Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q3 2024.
- Bellevue Life Sciences Acquisition Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $46K, a 64.6% decline year-over-year.
- Bellevue Life Sciences Acquisition Corp. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $377K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)